Suwon, South Korea

Jae-Kuk Ryu

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Science Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Kuk Ryu. Retrieved from https://idiyas.com/inventor/jae-kuk-ryu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae-Kuk Ryu: Innovator in Sustained Release Formulations

Introduction

Jae-Kuk Ryu is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. His work focuses on improving the delivery and effectiveness of medications.

Latest Patents

Jae-Kuk Ryu holds a patent for a "Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof." This innovative formulation can be easily and economically prepared. It is designed to maintain a constant drug level in the blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hours. This sustained release formulation is particularly effective for lowering blood cholesterol and triglyceride levels.

Career Highlights

Ryu's career is marked by his dedication to pharmaceutical innovation. He has been instrumental in developing formulations that enhance drug delivery systems. His work has the potential to significantly impact the treatment of conditions related to cholesterol and triglycerides.

Collaborations

Jae-Kuk Ryu has collaborated with several professionals in his field, including Jong Soo Woo and Hong-Gi Yi. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Jae-Kuk Ryu is a prominent figure in the pharmaceutical industry, known for his innovative work in sustained release formulations. His contributions are paving the way for more effective treatments in managing cholesterol and triglyceride levels.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…